Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-124474
Filing Date
2016-05-31
Accepted
2016-05-31 18:46:13
Documents
1
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3898
  Complete submission text file 0001209191-16-124474.txt   5246
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4560 WISMER ROAD DOYLESTOWN PA 18901
Business Address
Plotkin Stanley A (Reporting) CIK: 0001336537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 161687432